The NIFTY Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India.
Name | Percentage | Market Capitalization(in thousands Cr.) |
Abbott India | 2.52% | 9.44 |
Alembic Pharma | 2.54% | 9.50 |
Alkem Laboratories | 1.11% | 4.15 |
Aurobindo Pharma | 3.71% | 13.88 |
Biocon Ltd | 3.46% | 12.93 |
Cipla Ltd | 12.91% | 48.20 |
Divi’s Laboratories | 11.97% | 44.71 |
Dr. Reddy's Lab | 13.11% | 48.94 |
Gland Pharma Ltd | 3.66% | 13.70 |
Glenmark Pharma Ltd | 1.27% | 4.76 |
Granules India Ltd | 0.84% | 3.14 |
Ipca Laboratories Ltd | 3.17% | 11.84 |
Laurus Laboratories Ltd | 3.75% | 14.03 |
Lupin Ltd | 3.90% | 14.59 |
NATCO Pharma ltd | 1.55% | 5.79 |
Pfizer Ltd | 1.67% | 6.25 |
Strides Pharma Ltd | 0.46% | 1.74 |
Sun Pharma Ltd | 22.83% | 85.23 |
Torrent Pharma Ltd | 3.32% | 12.43 |
Zydus Lifesciences Ltd. | 2.26% | 8.46 |
NIFTY PHARMA | 100% | 373.31 |
There are a total of 4 companies from the Nifty Pharma Index which are included in the Nifty 50 Index. Sun Pharmaceuticals Ltd, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Divi’s laboratories Ltd.
With this, the Indian Pharma sector holds 2.3% share in the Nifty 50 Index.
Indian pharmaceutical companies are better placed to harness opportunities as they are competitive globally and hold a sizable market share in most markets.
Pharma sector stocks are affected by other factors too that are :-
Investing is the simplest way to set aside money while you are busy with life
and have that money work for you. To invest in Nifty 50 stocks you need to -